EUVIMEDEUVIMED entdecken
Crossref

Innovative design of CXCR4 cyclic peptide via molecular docking for 99mTc-Labeled SPECT/CT imaging in melanoma

Xianrui Yin, Xin Wang, Chengwei Chen, Shenglan Jia, Wanhong Li, Yihong Wu, Xin Chen, Danling Feng, Wai Ping Cecilia Tsang, Zhihao Han, Yueqing Gu

Analytica Chimica Acta · 2026

DOI: 10.1016/j.aca.2025.344754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Xianrui Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Ch…. Hauptthemen laut MEDLINE: Receptors, CXCR4, Molecular Docking Simulation, Peptides, Cyclic, Single Photon Emission Computed Tomography Computed Tomography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUD: The chemokine receptor CXCR4 is a crucial target for the diagnosis and treatment of cancer due to its close association with tumor growth, metastasis, invasiveness, and prognosis. RESULTS: The cyclic peptides KC1 and KC1E, along with their radiolabeled conjugates [99mTc]Tc-HYNIC-KC1 and [99mTc]Tc-HYNIC-KC1E, were successfully synthesized. The binding affinity of KC1 toward the CXCR4 receptor was evaluated using Surface Plasmon Resonance (SPR). Furthermore, key physicochemical and biological properties of the radiotracers were systematically assessed, including the oil-water partition coefficient (LogP), in vitro stability in normal saline solution and mouse serum, in vivo SPECT/CT imaging performance in a B16-F10 tumor-bearing mouse model, and biodistribution profiles following intravenous administration. SIGNIFICANCE: A novel cyclic peptide, KC1, was designed and shown to exhibit selective binding to the CXCR4 receptor. Molecular docking simulations were performed to elucidate the potential interaction mechanism between KC1 and CXCR4. The radiolabeled derivative [99mTc]Tc-HYNIC-KC1E was synthesized and demonstrated favorable in vivo imaging performance in B16-F10 tumor-bearing mice, supporting its potential as a promising imaging agent for CXCR4-positive tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR4Molecular Docking SimulationPeptides, CyclicSingle Photon Emission Computed Tomography Computed TomographyMelanoma, ExperimentalOrganotechnetium CompoundsDrug DesignRadiopharmaceuticalsAnimalsMiceTissue DistributionHumansTechnetiumMice, Inbred C57BLCell Line, Tumor

Stichwörter der Autor:innen

(99m)TcAutoDockB16–F10CXCR4SPECT/CTTargeted peptides

Substanzen

Receptors, CXCR4Peptides, CyclicOrganotechnetium CompoundsRadiopharmaceuticalsTechnetium

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China; Mianyang Key Laboratory of Anesthesia and Neuroregulation, Depart…
  • State Key Laboratory of Natural Medicine, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China; Department of Nuclear Medicine, The First Affiliated Hospit…
  • Department of Ophthalmology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
  • State Key Laboratory of Natural Medicine, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China.
  • State Key Laboratory of Natural Medicine, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: hanzhihao887@126.com.
  • State Key Laboratory of Natural Medicine, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: guengineering@cpu.edu.cn.

Förderung

  • Sichuan Provincial Science and Technology Support Program
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • China Pharmaceutical University

Zitieren

APA

Yin, X., Wang, X., Chen, C., Jia, S., Li, W., Wu, Y., Chen, X., Feng, D., Tsang, W. P. C., Han, Z., & Gu, Y. (2026). Innovative design of CXCR4 cyclic peptide via molecular docking for 99mTc-Labeled SPECT/CT imaging in melanoma. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344754

Vancouver

Yin X, Wang X, Chen C, Jia S, Li W, Wu Y, et al. Innovative design of CXCR4 cyclic peptide via molecular docking for 99mTc-Labeled SPECT/CT imaging in melanoma. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2025.344754

BibTeX
@article{Yin2026,
  author = {Yin, Xianrui and Wang, Xin and Chen, Chengwei and Jia, Shenglan and Li, Wanhong and Wu, Yihong and Chen, Xin and Feng, Danling and Tsang, Wai Ping Cecilia and Han, Zhihao and Gu, Yueqing},
  title = {Innovative design of CXCR4 cyclic peptide via molecular docking for 99mTc-Labeled SPECT/CT imaging in melanoma},
  journal = {Analytica Chimica Acta},
  year = {2026},
  doi = {10.1016/j.aca.2025.344754}
}
Kostenlos starten →